Featured on FierceBiotech: Lilly taps AbCellera to get coronavirus drug into clinic in 4 months

“Eli Lilly has teamed up with AbCellera to develop a treatment for the novel coronavirus. The partners aim to have an antibody in the clinic within four months, giving them a shot at contributing to efforts to counter the virus.”

Read full coverage on FierceBiotech.


Together we can make game-changing discoveries.